Biora Therapeutics Statistics
Want to see BIORQ full AI Analyst Report?
Biora Therapeutics (BIORQ) Stock Statistics & Valuation Metrics
Total Valuation
Biora Therapeutics has a market cap or net worth of $452.00. The enterprise value is $54.77M.
- Market Cap
- $452.00
- Enterprise Value
- $54.77M
Share Statistics
Biora Therapeutics has 4,522,702 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,522,702
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
Biora Therapeutics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- 68.966
- Profits Per Employee
- -2.14M
- Employee Count
- 58
- Asset Turnover
- ―
- Inventory Turnover
- ―
Valuation Ratios
The current PE Ratio of Biora Therapeutics is -0.00. Biora Therapeutics’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.11
- PB Ratio
- -0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Biora Therapeutics had revenue of 4,000 and earned -124.11M in profits. Earnings per share was -78.70.
- Revenue
- 4,000
- Gross Profit
- 4,000
- Operating Income
- -67.14M
- Pretax Income
- -124.42M
- Net Income
- -124.11M
- EBITDA
- -114.05M
- Earnings Per Share (EPS)
- -78.70
Cash Flow
In the last 12 months, operating cash flow was -5.37M and capital expenditures -280,000, giving a free cash flow of -5.50M billion.
- Operating Cash Flow
- -5.37M
- Free Cash Flow
- -5.50M
- Free Cash Flow per Share
- -30.81
Dividends & Yields
Biora Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10752654.87%
- Earnings Yield
- -78686818.03%
Stock Price Statistics
- Beta
- -56.00
- 52-Week Price Change
- -36.84%
- 50-Day Moving Average
- 0.17
- 200-Day Moving Average
- 0.59
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Biora Therapeutics upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Nov 17, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Taxes
In the past 12 months, Biora Therapeutics has paid -90.00K in taxes.
- Income Tax
- -90.00K
- Effective Tax Rate
- ―
Enterprise Valuation
Biora Therapeutics EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -0.66.
- EV to Sales
- 8053.86
- EV to EBITDA
- -0.28
- EV to Free Cash Flow
- -0.66
- EV to Operating Cash Flow
- -0.66
Balance Sheet
Biora Therapeutics has $3.20M in cash and marketable securities with $39.65M in debt, giving a net cash position of -$36.45M billion.
- Cash & Marketable Securities
- $3.20M
- Total Debt
- $39.65M
- Net Cash
- -$36.45M
- Net Cash Per Share
- -$8.06
- Tangible Book Value Per Share
- -$30.85
Margins
Gross margin is 100.00%, with operating margin of -1678575.00%, and net profit margin of -3102875.00%.
- Gross Margin
- 100.00%
- Operating Margin
- -1678575.00%
- Pretax Margin
- -3110600.00%
- Net Profit Margin
- -3102875.00%
- EBITDA Margin
- -2851350.00%
- EBIT Margin
- -2865225.00%
Analyst Forecast
The average price target for Biora Therapeutics is $45.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $45.00
- Price Target Upside
- 39030.43% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 7
